Related Experiment Video
Updated: Jul 18, 2025

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
Published on: December 11, 2017
Bicuspid aortic valve: long-term morbidity and mortality.
Li-Tan Yang1,2, Zi Ye1, Muhammad Wajih Ullah1
1Department of Cardiovascular Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
Bicuspid aortic valve (BAV) causes significant lifetime morbidity, with nearly all patients developing valvulo-aortopathy by age 90. While typical BAV has normal survival, complex BAV is linked to increased mortality.
Area of Science:
- Cardiology
- Genetics
- Public Health
Background:
- Bicuspid aortic valve (BAV) is the most prevalent congenital heart defect.
- Lifetime morbidity and survival variations in BAV patient subgroups remain unclear.
Purpose of the Study:
- To evaluate the lifetime morbidity burden in BAV patients.
- To assess long-term survival rates across different BAV patient subgroups.
Main Methods:
- Retrospective cohort study of Olmsted County residents diagnosed with BAV between 1980-2009.
- Patients categorized into typical and complex valvulo-aortopathy groups.
- Long-term follow-up to assess morbidity and survival outcomes.
Main Results:
- High lifetime morbidity (86%) observed by age 90, with 80.3% progressing to moderate or severe aortic stenosis/regurgitation.
- Typical BAV patients (86% of cohort) showed survival comparable to the general population.
- Complex BAV patients (14% of cohort) exhibited significantly higher mortality (relative excess risk 2.25).
Conclusions:
- BAV leads to substantial lifetime morbidity, with valvulo-aortopathy being nearly universal.
- Typical BAV is associated with normal long-term survival.
- Complex BAV significantly increases mortality risk, highlighting the need for risk stratification.
Related Concept Videos
Aortic Regurgitation I: Introduction
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Stenosis I: Introduction
Mitral Regurgitation I: Introduction
Mitral Stenosis II: Clinical features and Diagnostic Tests
Aortic Regurgitation III: Medical Management

